Dr Bryce Thompson Wyatt, MD | |
1357 Hembree Rd Ste 250, Roswell, GA 30076-5724 | |
(770) 475-7550 | |
Not Available |
Full Name | Dr Bryce Thompson Wyatt |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 10 Years |
Location | 1357 Hembree Rd Ste 250, Roswell, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134532609 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 82294 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Northside Hospital | Atlanta, GA | Hospital |
Northside Hospital Forsyth | Cumming, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Georgia Urology, Pa | 8921094376 | 71 |
Urological Professional Services, Llc | 9638391717 | 56 |
News Archive
Pfizer Oncology announced today that it will present new data from the company's pipeline, including two novel, dual PI3K/mTOR inhibitors (PF-04691502 and PKI-587, also known as PF-05212384); crizotinib (PF-02341066), an ALK inhibitor that also inhibits c-MET; and PF-04605412, an anti-α5β1 inhibitor.
Researchers in the United States have developed a new coronavirus disease 2019 (COVID-19) vaccine that induced potent neutralizing antibodies against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in animal models.
San Diego based neurosurgeon, Dr. Justin M. Brown, M.D., Director of the Neurosurgery Peripheral Nerve Program at UCSD School of Medicine, has implemented a procedure that helps patients recover movement in their hands and extremities after spinal cord and brain injuries, strokes, and other forms of paralysis.
UC San Francisco researchers have discovered a promising new line of attack against lethal, treatment-resistant prostate cancer. Analysis of hundreds of human prostate tumors revealed that the most aggressive cancers depend on a built-in cellular stress response to put a brake on their own hot-wired physiology.
› Verified 8 days ago
Entity Name | Georgia Urology, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245250646 PECOS PAC ID: 8921094376 Enrollment ID: O20040422000123 |
News Archive
Pfizer Oncology announced today that it will present new data from the company's pipeline, including two novel, dual PI3K/mTOR inhibitors (PF-04691502 and PKI-587, also known as PF-05212384); crizotinib (PF-02341066), an ALK inhibitor that also inhibits c-MET; and PF-04605412, an anti-α5β1 inhibitor.
Researchers in the United States have developed a new coronavirus disease 2019 (COVID-19) vaccine that induced potent neutralizing antibodies against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in animal models.
San Diego based neurosurgeon, Dr. Justin M. Brown, M.D., Director of the Neurosurgery Peripheral Nerve Program at UCSD School of Medicine, has implemented a procedure that helps patients recover movement in their hands and extremities after spinal cord and brain injuries, strokes, and other forms of paralysis.
UC San Francisco researchers have discovered a promising new line of attack against lethal, treatment-resistant prostate cancer. Analysis of hundreds of human prostate tumors revealed that the most aggressive cancers depend on a built-in cellular stress response to put a brake on their own hot-wired physiology.
› Verified 8 days ago
Entity Name | Urological Professional Services, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033521810 PECOS PAC ID: 9638391717 Enrollment ID: O20141104002579 |
News Archive
Pfizer Oncology announced today that it will present new data from the company's pipeline, including two novel, dual PI3K/mTOR inhibitors (PF-04691502 and PKI-587, also known as PF-05212384); crizotinib (PF-02341066), an ALK inhibitor that also inhibits c-MET; and PF-04605412, an anti-α5β1 inhibitor.
Researchers in the United States have developed a new coronavirus disease 2019 (COVID-19) vaccine that induced potent neutralizing antibodies against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in animal models.
San Diego based neurosurgeon, Dr. Justin M. Brown, M.D., Director of the Neurosurgery Peripheral Nerve Program at UCSD School of Medicine, has implemented a procedure that helps patients recover movement in their hands and extremities after spinal cord and brain injuries, strokes, and other forms of paralysis.
UC San Francisco researchers have discovered a promising new line of attack against lethal, treatment-resistant prostate cancer. Analysis of hundreds of human prostate tumors revealed that the most aggressive cancers depend on a built-in cellular stress response to put a brake on their own hot-wired physiology.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Bryce Thompson Wyatt, MD 1930 Brannan Rd, Mcdonough, GA 30253-4310 Ph: (678) 284-4686 | Dr Bryce Thompson Wyatt, MD 1357 Hembree Rd Ste 250, Roswell, GA 30076-5724 Ph: (770) 475-7550 |
News Archive
Pfizer Oncology announced today that it will present new data from the company's pipeline, including two novel, dual PI3K/mTOR inhibitors (PF-04691502 and PKI-587, also known as PF-05212384); crizotinib (PF-02341066), an ALK inhibitor that also inhibits c-MET; and PF-04605412, an anti-α5β1 inhibitor.
Researchers in the United States have developed a new coronavirus disease 2019 (COVID-19) vaccine that induced potent neutralizing antibodies against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in animal models.
San Diego based neurosurgeon, Dr. Justin M. Brown, M.D., Director of the Neurosurgery Peripheral Nerve Program at UCSD School of Medicine, has implemented a procedure that helps patients recover movement in their hands and extremities after spinal cord and brain injuries, strokes, and other forms of paralysis.
UC San Francisco researchers have discovered a promising new line of attack against lethal, treatment-resistant prostate cancer. Analysis of hundreds of human prostate tumors revealed that the most aggressive cancers depend on a built-in cellular stress response to put a brake on their own hot-wired physiology.
› Verified 8 days ago
Dr. Sophia D Goodridge, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2500 Hospital Blvd Ste 290, Roswell, GA 30076 Phone: 470-956-4230 | |
Lewis S Kriteman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1357 Hembree Rd, Suite 250, Roswell, GA 30076 Phone: 770-475-7550 Fax: 770-343-9080 | |
Dr. Kushan Radadia, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 11660 Alpharetta Hwy Ste 700, Roswell, GA 30076 Phone: 678-839-9973 Fax: 470-427-2013 | |
Daniel Rahe Belew, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1357 Hembree Rd Ste 250, Roswell, GA 30076 Phone: 770-475-7550 | |
Adamantios Michael Mellis, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1357 Hembree Rd, Ste 250, Roswell, GA 30076 Phone: 678-284-4040 Fax: 678-284-4076 | |
Rutveej Patel, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 11660 Alpharetta Hwy Ste 700, Roswell, GA 30076 Phone: 678-344-8900 Fax: 678-666-5201 |